News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

June 6, 2022
June 6, 2022
Categories

E2211: Dr. Pamela Kunz discusses the trial results and talks about the challenges of managing endocrine tumors

Do you like it?
Read more
June 6, 2022
June 6, 2022
Categories

Dr. Michael Atkins discusses the DREAMseq trial in patients with advanced melanoma

Do you like it?
Read more
June 5, 2022
June 5, 2022
Categories

Dr. Pamela Kunz on pancreatic neuroendocrine tumors: A final analysis of temozolomide or temozolomide plus capecitabine

Do you like it?
Read more
June 5, 2022
June 5, 2022
Categories

Drug combination shows promise for treating pancreatic neuroendocrine tumors

Do you like it?
Read more
June 4, 2022
June 4, 2022
Categories

E3311: No differences in survival outcomes based on tobacco history in HPV-associated head and neck cancer

Do you like it?
Read more
June 1, 2022
June 1, 2022
Categories

Precision medicine clinical trials: A conversation between Peter O’Dwyer and Lale Kostakoglu

Do you like it?
Read more
May 27, 2022
May 27, 2022
Categories

Press Release: ECOG-ACRIN research highlights at ASCO 2022

Do you like it?
Read more
May 19, 2022
May 19, 2022
Categories

Dr. Alicia Morgans on going beyond ADT for metastatic prostate cancer

Do you like it?
Read more
May 17, 2022
May 17, 2022
Categories

Media Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio

Do you like it?
Read more
May 5, 2022
May 5, 2022
Categories

The current state of metastatic melanoma (a series of four videos)

Do you like it?
Read more
May 4, 2022
May 4, 2022
Categories

Dr. Kevin Kalinsky discusses updates from the TAILORx breast cancer trial

Do you like it?
Read more
April 29, 2022
April 29, 2022
Categories

Interview with Dr. Robert Ferris: Head and neck cancer treatment evolution leads the way for future developments

Do you like it?
Read more
April 11, 2022
April 11, 2022
Categories

As NCI-MATCH winds down, cancer research community takes stock of lessons learned

Do you like it?
Read more
April 9, 2022
April 9, 2022
Categories

Study finds potential association between allostatic load and worse overall survival in multiple myeloma

Do you like it?
Read more
April 9, 2022
April 9, 2022
Categories

Mixed quality of life findings following treatment highlight need for breast cancer support services

Do you like it?
Read more
April 7, 2022
April 7, 2022
Categories

African ancestry, high BMI predictive of worse breast cancer outcomes

Do you like it?
Read more
March 25, 2022
March 25, 2022
Categories

Enrollment in TMIST breast cancer screening trial surpasses halfway mark; Black participation rises above 20%

Do you like it?
Read more
March 25, 2022
March 25, 2022
Categories

Press Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success

Do you like it?
Read more
March 17, 2022
March 17, 2022
Categories

NCI-MATCH umbrella trial adds arm for LAG-3 expressing, mismatch repair deficient cancers

Do you like it?
Read more
March 16, 2022
March 16, 2022
Categories

Press Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

Do you like it?
Read more
Load more
News and Info

News

News and Info
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Categories


Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Bladder cancer Blood cancer Brain Cancer Breast cancer Cancer screening Cancer treatment Chemotherapy Clinical trial ComboMATCH Disparities Diversity Gastric cancer Gene testing GI cancer Group meeting Head and neck cancer Health equity Immunotherapy In memory Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma NCI-MATCH Non-Hodgkin lymphoma Pancreatic cancer Personalized screening Personalized treatment Precision medicine Precision oncology Prostate cancer Radiology Research results Sarcoma Social determinants of health (SDoH) Survivorship Targeted therapy TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group